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Durability and inflammogenic impact of carbon
nanotubes compared with asbestos fibres
Megan J Osmond-McLeod1*, Craig A Poland2,6, Fiona Murphy2, Lynne Waddington3, Howard Morris4,
Stephen C Hawkins5, Steve Clark6, Rob Aitken6, Maxine J McCall1 and Ken Donaldson2
Abstract
Background: It has been suggested that carbon nanotubes might conform to the fibre pathogenicity paradigm
that explains the toxicities of asbestos and other fibres on a continuum based on length, aspect ratio and
biopersistence. Some types of carbon nanotubes satisfy the first two aspects of the fibre paradigm but only
recently has their biopersistence begun to be investigated. Biopersistence is complex and requires in vivo testing
and analysis. However durability, the chemical mimicking of the process of fibre dissolution using in vitro
treatment, is closely related to biopersistence and more readily determined. Here, we describe an experimental
process to determine the durability of four types of carbon nanotubes in simulated biological fluid (Gambles
solution), and their subsequent pathogenicity in vivo using a mouse model sensitive to inflammogenic effects of
fibres. The in vitro and in vivo results were compared with well-characterised glass wool and asbestos fibre controls.
Results: After incubation for up to 24 weeks in Gambles solution, our control fibres were recovered at percentages
consistent with their known in vitro durabilities and/or in vivo persistence, and three out of the four types of
carbon nanotubes tested (single-walled (CNTSW) and multi-walled (CNTTANG2, CNTSPIN)) showed no, or minimal, loss
of mass or change in fibre length or morphology when examined by electron microscopy. However, the fourth
type [multi-walled (CNTLONG1)] lost 30% of its original mass within the first three weeks of incubation, after which
there was no further loss. Electron microscopy of CNTLONG1 samples incubated for 10 weeks confirmed that the
proportion of long fibres had decreased compared to samples briefly exposed to the Gambles solution. This loss of
mass and fibre shortening was accompanied by a loss of pathogenicity when injected into the peritoneal cavities
of C57Bl/6 mice compared to fibres incubated briefly. CNTSW did not elicit an inflammogenic effect in the
peritoneal cavity assay used here.
Conclusions: These results support the view that carbon nanotubes are generally durable but may be subject to
bio-modification in a sample-specific manner. They also suggest that pristine carbon nanotubes, either individually
or in rope-like aggregates of sufficient length and aspect ratio, can induce asbestos-like responses in mice, but that
the effect may be mitigated for certain types that are less durable in biological systems. Results indicate that
durable carbon nanotubes that are either short or form tightly bundled aggregates with no isolated long fibres are
less inflammogenic in fibre-specific assays.
Background
It has been suggested that the potential pathogenicity of
carbon nanotubes (CNTs) might conform to the ‘fibre
pathogenicity paradigm’, by which a fibre’s pathogenicity
can be predicted on a continuum based on its length and
biopersistence (Figure 1), as well as aspect ratio. On this
continuum, fibres that are more likely to induce ‘asbestos-
like’ pathologies such as asbestosis, lung cancer, and
mesothelioma will be narrow enough that they can reach
the distal lung upon inhalation, long enough to be incom-
pletely engulfed by macrophages during clearance, and
resistant to chemical attack or breakage in a biological
environment. Deposition of long, narrow, biopersistent
fibres into the distal lung region can be problematic to
health if local macrophage-mediated clearance is only par-
tially successful and instead results in a state of chronic
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macrophage stimulation (so-called ‘frustrated phagocyto-
sis’). The sustained release of inflammatory mediators may
then lead to inflammatory, fibrotic and carcinogenic out-
comes [1]. Oberdorster (2000) regards fibres > 20 μm long
as being of sufficient length to induce these kinds of fibre-
induced pathogenic effects [2].
CNTs possess properties such as exceptional strength,
lightness and conductivity that make them valuable for
industrial and medical applications [3,4], but can be
manufactured to reach potentially pathogenic lengths.
Indeed, their morphological similarity to asbestos fibres
raised early concerns about possible adverse effects on
human health [5]. However CNTs are prone to form
aggregates due to strong hydrophobic forces and this
could impact on their ability to become airborne as
individual fibres at high concentrations under con-
trolled, small-scale conditions [6-8]. Notwithstanding
their propensity to aggregate, if individual CNTs or
small bundles were to be incidentally or accidentally
aerosolised with a respirable aerodynamic diameter it is
possible they could align lengthwise with the airstream
and reach the distal lung [9]. Additionally, the increased
risk of exposure that might arise in large-scale manufac-
turing environments has been noted [10].
In addition to length and aspect ratio, biopersistence (i.
e. the ability of a material to persist in the body in spite
of physiological clearance mechanisms) is regarded as
one of the most important determinants of a fibre’s
pathogenicity [2,9]. Biopersistent fibres resist the leaching
or solubilisation of structural elements within a biological
environment such as the lung-lining fluid or the internal
environment of macrophages. Less biopersistent fibres, in
contrast, can weaken and break at the weakened points,
thus becoming short enough for successful clearance [1].
CNTs were initially thought to be resistant to chemical
attack due to their essentially graphitic nature [9], and
indeed both single-walled (SW) and multi-walled (MW)
CNTs have been shown to persist in vivo up to months
post-exposure in mice and rats [11-13]. However, other
reports have suggested that certain types of SWCNTs
and MWCNTs may be subject to degradation in biologi-
cal environments [14-17]. This broaches the possibility
that whilst some CNTs may have pathogenic potential in
their pristine form, they may lose this if they are vulner-
able to degradation in the biological milieu.
Durability is a key factor in determining fibre biopersis-
tence. Thus, measurement of durability has been used
with success to predict biopersistence [1], although it is
not without its drawbacks [2]. Here, we describe experi-
ments designed to assess the durability in simulated biolo-
gical fluid (Gambles solution) of four types of CNTs
compared with one type of glass wool fibre (X607) and
two types of asbestos fibres [long fibre amosite (LFA) and
long fibre chrysotile (LFC)]. The four types of CNTs tested
included one single-walled (CNTSW) and three multi-
walled CNTs [’spinnable’ (CNTSPIN); ‘long’ (CNTLONG1);
and ‘tangled’ (CNTTANG2)], where the names for the latter
two samples are taken from Poland et al. [18] (Table 1).
Following incubation in Gambles solution we assessed the
loss of mass as a measure of durability, and then examined
a subset of these fibres (following either minimal or
lengthy exposure to Gambles solution) for their ability to
induce an inflammatory response when injected into the
peritoneal cavities of female C57Bl/6 mice in order to
assess the impact of durability on CNT fibre-induced
pathogenicity. These data should assist in the placement
of CNTs on the spectrum of potentially pathogenic fibres
in order to inform their safe use.
Results
In vitro durability of test samples
Gambles solution is a balanced electrolyte solution simi-
lar to the electrolyte environment of biological systems.
Fibre?exposure?
Deposition?
Short?fibres?
Effective?
phagocytosis?and?
macrophage?
clearance?
Cleared?
Non?biopersistent
Long?fibres
Dissolution
Breakage Dissolved
Biopersistent?
Incomplete?
phagocytosis,?cell?
activation,?and?failed?
clearance?
Inflammation,?
fibrosis,?cancer?
Figure 1 Paradigm for the role of length and biopersistence in
the pathogenic effects of fibres. Schematic outlining the possible
fates for fibres in vivo based on length and biopersistence (from
Donaldson et al. 2006). Long, narrow (not depicted) and
biopersistent fibres that deposit in the distal lung regions may
cause inflammation, fibrosis and/or cancer.
Table 1 Fibres investigated in this study and rationale
for their use
Fibre Source Rationale for Use
X607 Rockwool
International
Non-durable glass wool control
LFA Archival samples Durable amosite asbestos control
LFC Archival samples Non-durable chrysotile asbestos
control
CNTSW Sigma-Aldrich Unknown durability
CNTSPIN CSIRO Australia Unknown durability
CNTLONG1 Mitsui & Co Unknown durability
CNTTANG2 NanoLab Inc Unknown durability
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Its pH is adjusted to mimic that inside macrophage pha-
golysosomes, potentially the most degradative environ-
ment that a particle should encounter following lung
deposition and macrophage uptake. Fibre durability was
assessed by incubating controls and test samples in
quadruplicate in Gambles solution for defined times
throughout a 24 week experimental period, and deter-
mining percent recoveries of original weight after filter-
ing and drying (Figure 2). Samples recovered at 100% of
their original weights are described as 100% durable.
Of the control fibres, the non-durable glass fibre,
X607, was recovered with ~40% of its original weight
after the 24 week incubation, while the “durable” asbes-
tos fibre, LFA, was recovered at ~75%. The other asbes-
tos fibre examined here, LFC, was recovered with ~30%
of original weight over the same period. None of the
CNT samples showed a significant loss of mass by week
24 with the exception of CNTLONG1, which was recov-
ered at only ~70% of its original weight at all time-
points from week 3 onward. A small but statistically sig-
nificant increase in mass was observed for the CNTSPIN
sample at week 24. CNTSW and CNTTANG2 showed
some variation in percent recoveries across the time-
points but these were generally neither consistent nor
statistically significant (Table 2).
Sources of error in sample recoveries may include
sample preparation by different operators, loss of sam-
ple during refreshing of Gambles solution, and loss of
sample during filtration, reflecting general difficulties
in handling CNT samples. We estimate that these
sources of error may account for up to 20% of varia-
tion in sample recovery. Therefore, variation of 20%
from the original mass may not reflect true differences
in recoveries, unless the 20% was part of a consistent
trend across all time-points. On this basis, despite
reaching apparent statistical significance for one mea-
surement, we suggest that the variations in percent
recoveries for CNTSW, CNTTANG2 and CNTSPIN reflect
experimental error, as consistent trends were not evi-
dent across all time-points for these samples. In con-
trast, the loss of mass observed for CNTLONG1 was
consistent and statistically significant across most
time-points. Of the control fibres, we suggest that per-
cent recoveries for X607 and LFC reflect true mass
loss, whereas the small mass loss for LFA over the 24
week period may be due to the loss of small fibres in
the sample (discussed later).
TEM images of samples that had been incubated for 0
weeks or 10 weeks in Gambles solution were taken at
various magnifications, and the widths and lengths of
fibres in these images were measured using Image J
(NIH) calibrated software (Table 3). Size distributions
are shown in Figure 3, and representative SEM and
TEM images in Figure 4.
The X607 sample (Figure 4A) contained the largest
fibres assessed here, with widths in the micrometre
range and average lengths markedly greater than 20
μm. Whilst fewer long fibres remained after 10 weeks
Figure 2 Durabilities of CNT samples and controls in simulated biological fluid. The weights of quadruplicate samples of glass wool fibre
(X607), asbestos fibres (LFA, LFC) and CNT test samples (CNTSW, CNTSPIN, CNTLONG1 and CNTTANG2), recovered from Gambles solution following
incubation for various times are expressed relative to the weight of sample recovered at 0 weeks.
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incubation, of those that remained a high proportion
were still very large (Table 3, Figure 3). Nevertheless,
the average width of these remaining fibres decreased
from 3.5 to 2.1 μm and length decreased from 123 μm
to 76 μm.
LFA showed an apparent increase in average fibre
width and length as a result of the incubation. The pro-
portion of long fibres also appeared to increase (Table
3, Figure 3). It is possible that the loss of mass at the
last two time-points for this sample (Figure 2) reflects
the loss of smaller fibres, leaving, on average, a greater
proportion of larger fibres remaining in the recovered
75%. This would potentially bias the average width and
length to the larger end of the size distributions. The
fibres remaining at 10 weeks did not show any morpho-
logical differences from those at 0 weeks when viewed
by electron microscopy (Figure 4B).
LFC showed no difference in average fibre width with
incubation but did show a marked decrease in length
(Table 3, Figure 3). We note that at 0 weeks the LFC
sample comprised a mixture of fibrils and ropes of
fibrils (Figure 4C). All were measured in the 0 weeks
sample, potentially assigning erroneously large measure-
ments to individual fibres, whereas at 10 weeks only
small fibrils remained, resulting in average length mea-
surements at the shorter end of the distribution. Given
this sample also showed a marked loss of mass, it is
probable that the measured loss of length accurately
reflects fibre shortening in addition to the breaking up
of large fibre bundles.
CNTSW did not show an alteration in average fibre
width or length arising from incubation in Gambles
solution (Table 3, Figure 3). It also showed little mor-
phological change under electron microscopy (Figure
4D), with the majority of fibres forming large clumps.
Generally, individual fibres could be seen only at the
edges.
Lengths for CNTSPIN could not be determined due to
their very long, hair-like nature, making the starts and
ends of individual tubes virtually impossible to identify
(Figure 4E). The average width showed an apparent
slight increase after 10 weeks incubation in Gambles
solution (Table 3, Figure 3). We cannot explain this
result, apart from noting the difficulty in identifying
individual fine tubes in this sample.
CNTLONG1 samples that had been incubated in Gam-
bles solution for 3 weeks and 10 weeks showed no
decrease in average fibre width compared with the start-
ing material, but did show small, statistically significant
decreases in the average length. Additionally, there was
a decrease in the proportion of long fibres present com-
pared to samples incubated for 0 weeks, with approxi-
mately 50% fewer fibres with lengths >15 μm in samples
incubated for 10 weeks compared to 0 weeks (Table 3,
Figure 3). TEM images at 0 weeks and 10 weeks show
that many fibres in this sample contained what may be
residual catalyst material or amorphous carbon (Figure
4F), as well as a large number of what appear to be
curled CNTs decorating the straighter fibres (more
Table 2 Weights of samples recovered from Gambles
solution at 0 weeks and various incubation times to 24
weeks
Sample ID Incubation Period (week) % Week 0 Recovery ± SE
X607 0 100 ± 2.09
3 75.8 ± 5.46 *
6 59.2 ± 3.2 *
10 46.86 ± 3.07 *
24 37.82 ± 6.6 *
LFA 0 100 ± 1.55
3 95.53 ± 1.48
6 94.13 ± 1.2
10 83.76 ± 2.62 *
24 75.43 ± 1.33 *
LFC 0 100 ± 0.3
3 77.26 ± 2.93 *
6 75.8 ± 2.6 *
10 53.79 ± 1.42 *
24 28.23 ± 3.03 *
CNTSW 0 100 ± 2.46
3 103.92 ± 3.94
6 107.08 ± 2.85
10 101.51 ± 2.69
24 88.68 ± 6.4
CNTSPIN 0 100 ± 3
3 99.14 ± 1.23
6 101.92 ± 1.39
10 102.18 ± 1.36
24 114.18 ± 2.91*
CNTLONG1 0 100 ± 1.36
3 70.37 ± 6.75 *
6 71.99 ± 3 *
10 80.19 ± 7.41
24 70.76 ± 2.59 *
CNTTANG2 0 100 ± 23.85
3 94.23 ± 6.01
6 94.84 ± 14.94
10 108.39 ± 15.83
24 74.06 ± 2.58
Recovered weights of incubated samples in quadruplicate are expressed as
percent relative to the recovered weight at 0 weeks, and presented here as
mean ± standard error (SE) of the mean. The statistical significance of
differences from the recoveries at 0 weeks were assessed by one-way ANOVA
with Tukey’s Multiple Comparison post-test. A statistically significant
difference from the recovery at 0 weeks was set at p < 0.05 and is denoted
by an asterisk.
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clearly seen in images at higher magnification, not
shown).
The lengths of CNTTANG2 fibres were not able to be
determined due to their ‘tangled’ nature and subsequent
difficulties in identifying discrete tubes from start to
end. Their average width (Table 3, Figure 3) and general
morphology (Figure 4G) did not change as a result of
the incubation in Gambles solution when viewed by
electron microscopy.
In vitro determination of the impact of 1 h bath
sonication on mass loss and changes in fibre dimensions
for CNTLONG1
It has been reported elsewhere that sonication can
mechanically shear CNTs, with the degree of damage
depending on the type of CNT and sonication condi-
tions [19]. As our 0 weeks samples were not sonicated,
but the other samples were, we performed a small sup-
plementary experiment to determine if the 1 h gentle
bath sonication of the incubated fibres was responsible
for the fibre shortening observed for the CNTLONG1
sample, rather than the incubation in Gambles solution.
In this experiment, CNTLONG1 samples were either first
sonicated for 1 h in Gambles solution, or were simply
added to Gambles solution and then immediately fil-
tered, dried and weighed, and then fibre lengths were
measured, replicating the conditions by which we
produced our original 0 weeks samples. The results
showed no mass loss resulting from the 1 h sonication,
and no statistical difference in the average fibre length
or proportion of long fibres (data not shown). In addi-
tion, we examined filtrates from the original 0 weeks
and 10 weeks samples, as well as from the new 0 h and
1 h sonicated samples. Only the original samples incu-
bated for 10 weeks in Gambles solution contained CNT
debris (CNT fragments approximately 500 nm long).
These results provide strong evidence for the observed
mass loss and fibre shortening of 10 weeks CNTLONG1
samples being caused by incubation in Gambles solution
and not by sonication under our experimental
conditions.
In vivo inflammogenic response to test samples
Samples that had been incubated in Gambles solution
for 0 weeks or 10 weeks were filtered and resuspended
in 0.5% bovine serum albumin (BSA):saline at a pre-
sumed 100% recovery of mass, and a presumed mass of
50 μg was injected into the peritoneal cavities of female
C57Bl/6 mice. Mice were sacrificed at 24 h or 7 d post-
injection and the peritoneal cavities were washed and
lavage fluid collected. To identify the presence of an
acute inflammatory response, a number of assays were
performed: total and differential cell counting to identify
possible infiltration of immune cells into the peritoneal
Table 3 Average widths and lengths, and length distributions, of samples incubated in Gambles solution for 0 weeks
or 10 weeks, as determined by TEM measurements
Sample Incubation
Period (week)
Width (nm)
± SE
Length
μ(m) ± SE
% ≥ 100
μm
100 μm > % ≥
20 μm
20 μm > % ≥
15 μm
15 μm > % ≥
10 μm
10 μm > % ≥
5 μm
% < 5
μm
X607 0 3500 ± 190 123 ± 7 58 36 4 1 1 0
10 2100 ± 169* 76 ± 5* 33 55 6 3 2 0
LFA 0 550 ± 39 34 ± 3 5 50 8 16 13 8
10 820 ± 52* 56 ± 4* 18 56 6 6 7 6
LFC 0 42 ± 1 10.8 ± 1 0 20 6 9 17 49
10 43 ± 2 1.9 ± 0.3* 0 0 0 0 0 100
CNTSW 0 5 ± 0.3 3.6 ± 0.2 0 0 0 0 19 81
10 5 ± 0.3 3.2 ± 0.4 0 0 0 0 18 82
CNTSPIN 0 9 ± 0.3 NAs NAs NAs NAs NAs NAs NAs
10 14 ± 0.3* NAs NAs NAs NAs NAs NAs NAs
CNTLONG1 0 60 ± 2 12.4 ± 0.5 0 10 20 29 37 4
3 65 ± 2 10.9 ± 0.5* 0 8 10 27 45 10
10 63 ± 2 11.1 ± 0.4* 0 4 9 42 38 7
CNTTANG2 0 10 ± 0.4 NAs NAs NAs NAs NAs NAs NAs
10 10 ± 0.4 NAs NAs NAs NAs NAs NAs NAs
The dimensions of fibres, for which a start and end point could be identified in representative TEM images, were measured using Image J (NIH) calibrated
software. The mean widths and lengths of samples incubated for 10 weeks were compared to their equivalent 0 weeks samples by an unpaired t-test, where
statistical significance was set at p < 0.05 (denoted by an asterisk). Fibre dimensions were additionally determined for CNTLONG1 at 3 weeks incubation to assess
whether the shortening seen at 10 weeks was part of a consistent trend.
NAs: not assessable
Note: Due to the difficulty in identifying and measuring individual CNTs within bundles in TEM images, these numbers should not be taken as absolute but
indicative of trends only.
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cavities in response to the treatments (Figure 5A, B);
measurement of total protein as a marker for increased
permeability in the peritoneal cavity (Figure 5C); mea-
surement of the cytokine, IL-6, as a marker for the
release of inflammatory cytokines (Figure 5D); and mea-
surement of LDH as a marker for damage to cellular
membranes (Figure 5E). The development of fibrotic
plaques at 7 d was also assessed (Figure 5F). CNTTANG2
and CNTSPIN were not included in the in vivo analysis
because the former had been shown previously to be
non-pathogenic in a similar study [18], and the latter
was not able to be dispersed well enough to inject a reli-
able amount of sample into the mice.
X607 did not elicit a statistically significant inflamma-
tory response with the exception of the total cell count
for the 7 d sample, regardless of incubation time in
Gambles solution, although it should be noted that
some biomarkers were elevated compared to levels in
mice treated with vehicle only. LFA elicited an acute
inflammatory response in mice in addition to the devel-
opment of fibrotic plaques by 7 d, regardless of incuba-
tion time, suggesting that long-term incubation did not
alter its pathogenicity. In contrast, LFC that had been
incubated in Gambles solution for 0 weeks induced total
and differential cell counts, total protein, and IL-6 levels
indicative of an acute inflammatory response that subse-
quently subsided by 7 d alongside the development of a
fibrotic response, whereas LFC that had been incubated
for 10 weeks had a reduced inflammogenic response at
24 h, although interestingly, not at 7 d; at 7 d the total
cell count was higher in mice injected with the LFC
incubated for 10 weeks compared to LFC that had been
incubated for 0 weeks, as well as higher than LFA. How-
ever, LFC that had been incubated for 10 weeks did not
induce a fibrotic response at 7 d whereas LFC incubated
for 0 weeks or LFA incubated for 0 weeks or 10 weeks
did. CNTSW did not induce an inflammatory response
under the experimental conditions studied here.
CNTLONG1 incubated in Gambles solution for 0 weeks
induced an acute inflammatory response at 24 h post-
injection into mice that did not subside by 7 d, and also
induced a strong fibrotic response at 7 d. However,
CNTLONG1 that had been incubated in Gambles solution
for 10 weeks was less pathogenic in mice, inducing
reduced inflammatory and fibrotic responses compared
to 0 weeks (Figure 6).
The inflammatory responses in vivo, combined with
the durability data in vitro, are summarised in Table 4.
Taken together, the data indicate that CNTLONG1 and
LFC showed some mass loss and fibre shortening with
long-term incubation in Gambles solution, with a con-
comitant mitigation of the pathogenicity seen in mice
injected with 0 weeks samples. LFA that had been incu-
bated for 10 weeks, on the other hand, also showed a
loss of mass comparable to CNTLONG1 at the same
time-point, but no fibre shortening, and did not lose its
pathogenicity (Figure 6). These observations suggest that
the loss of pathogenicity under these experimental
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Figure 3 Effect of incubation in Gambles solution on fibre
widths and lengths. Boxplots showing the distribution of fibre
widths and lengths (nm) in samples that had been incubated in
Gambles solution for 0 weeks or 10 weeks. The line in the box
represents the median value of measurements from TEM images,
and the edges of the box represent the lower and upper quartiles.
The ends of the whiskers represent minimum and maximum values.
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conditions may have been associated more with the
decreased proportion of long fibres than loss of mass.
Discussion
Our study demonstrates that the types of carbon nano-
tubes investigated here conform to the “fibre pathogeni-
city paradigm”. Where CNTs were injected to the
abdominal cavities of mice as long discrete fibres or
fibre-like structures, as in the case of CNTLONG1 (0
weeks incubation in Gambles solution), an inflammatory
and fibrotic response was induced. However, where no
or relatively few long fibres were present, as in the case
of CNTLONG1 after 10 weeks incubation in Gambles
solution, where the proportion of fibres >15 μm was
SEM
0wk 10wk 0wk 10wk
A. X607
TEM
B. LFA
300μm 300μm
C LFC
50μm 50μm
.
3μm 3μm
D. CNTSW
2μm 2μm
E. CNTSPIN
10μm 10μm
F. CNTLONG1
10μm 10μm
G. CNTTANG2
2μm 2μm
Figure 4 Appearance of fibres before and after incubation in Gambles solution. Representative SEM images of samples after 0 weeks or 10
weeks incubation in Gambles solution are shown at 5.0 K magnification in the two panels on the left. TEM images of equivalent samples, at
indicated magnifications, are on the right.
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Figure 5 Inflammatory responses to test samples injected into the peritoneal cavities of mice. Samples of vehicle only, X607, LFA, LFC,
CNTSW and CNTLONG1, incubated for either 0 weeks or 10 weeks in Gambles solution, were injected into the peritoneal cavities of mice, and
inflammatory responses were assessed at 24 h (panels on left) and 7 d (panels on right) post-injection. The inflammatory response was assayed
by total (A) and differential (B) cell counts to identify infiltration of immune cells into the peritoneal cavity, total protein (C) to indicate increased
permeability in the peritoneal cavity, IL-6 (D) as a measure of inflammatory cytokines, LDH (E) to indicate damage to cellular membranes, and
the development of fibrotic plaques at 7 d (G). Note that the scales of the vertical axes vary. Differences between mice treated with the same
fibre samples incubated for 0 weeks or 10 weeks were assessed by unpaired t-tests, with statistical significance set at p < 0.05 (denoted by an
asterisk). Differences between mice treated with fibres that had been incubated for 0 weeks or 10 weeks compared to mice treated with vehicle
only were assessed by one-way ANOVA with Tukey’s Multiple Comparison post-test, with statistical significance set at p < 0.05 (denoted by an
unshaded triangle). For the differential cell counts, statistically significant differences between the numbers of macrophages (MAC) and
polymorphonuclear leukocytes (PMNs) in treated mice compared to control mice are denoted by an unshaded triangle or a black square,
respectively.
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Figure 6 Fibrotic plaques on the peritoneal face of the diaphragm following intraperitoneal instillation of CNTLONG1 and LFA fibres. A.
Differential development of fibrotic plaques on the peritoneal face of the diaphragm following the injection of CNTLONG1 or LFA fibres that had
been incubated for 0 weeks (left panels) or 10 weeks (right panels). Black rods indicate the depth of the fibrotic plaque and show that 10 weeks
incubation in Gambles solution did not impact the response to LFA fibres, whereas the fibrotic response from CNTLONG1 0 weeks was largely
absent in mice injected with CNTLONG1 10 weeks. Co-localisation of fibrotic plaques with CNTLONG1 fibres (B) or LFA fibres (C) (indicated by black
chevrons) is also shown.
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markedly reduced, or in the case of CNTSW, where the
fibrous shape of individual tubes was masked by tight
bundling, the inflammatory response was minimal. Our
results are consistent with a previous study also using
the peritoneal cavity as a surrogate model for exposure
of the thoracic mesothelium to particles, where a range
of MWCNTs or asbestos fibres were directly injected
into the abdominal cavities of mice; only those samples
containing long, discrete fibres elicited an “asbestos-like”
response [18], while fibres that were either short and/or
in the form of tight bundles were not pathogenic.
Further, the ability of inhaled MWCNT to reach sub-
pleural tissues in mice has also been reported [20,21],
indicating that MWCNTs can share a characteristic
with asbestos that is critical for the development of
asbestos-related mesothelioma [22]. Thus we may expect
that a fibre-like pathogenicity might be induced by any
type of CNT that reaches the sub-pleural tissue if the
CNT presents as a discrete long fibre or fibre-like struc-
ture, and that shape persists.
As expected, the control fibres also largely conformed
to the fibre pathogenicity paradigm. LFA is known to be
durable and pathogenic [23]. Although short fibres of
LFA disappeared upon incubation in Gambles solution,
accompanied by a small loss of mass, the long fibres
endured and, when injected into abdominal cavities of
mice, LFA induced a strong inflammatory response con-
sistent with the presence of durable, long fibres with
high aspect ratios. X607 is an experimental alkaline
earth silica wool with high CaO content (personal com-
munication O. Kamstrup, Rockwool International)
found to be non-biopersistent in animal studies [24],
while chrysotile asbestos (LFC) is considered to be the
least biopersistent of the asbestiform minerals and has
shorter clearance half-times in inhalation studies [25,26].
Both of these fibres showed a loss of mass upon incuba-
tion in Gambles solution, and this was accompanied by
surface etching and splitting, and fibre thinning and/or
shortening, respectively, as revealed by electron micro-
scopy. LFC injected into mice after 0 weeks incubation
induced a strong inflammatory response, whereas the
incubation-mediated degradation mitigated its inflam-
matory potential. Nevertheless, it is interesting to note
that at 7 d post-injection, the inflammatory response for
LFC was greater than for LFA, but the former did not
elicit a fibrotic response whereas the latter did. The
development of granulomas is associated with a decrease
in the lavageable polymorphonuclear leukocytes and
Table 4 Summary of results from experiments to determine durability, and acute and 7 d inflammatory responses in
vivo, for CNT samples and controls
Fibre Changes Acute Inflammatory Response (24 h) 7 d Inflammatory Response
Loss of
Mass
Fibre
Shortening
Total
Cell
PMN
Infiltration
Total
Protein
IL-
6
LDH Total
Cell
PMN
Infiltration
Total
Protein
IL-
6
LDH Granuloma
Response
X607 0
week
N/A N/A - - - - - - - - - - -
10
week
+ + - - - - - - - - - - -
LFA 0
week
N/A N/A + + - - - - - - - - Yes (ns)
10
week
+ - + + - - - - - - - - Yes (ns)
LFC 0
week
N/A N/A + + + - - - - - - - Yes (ns)
10
week
+ + - - - - - - - - - - -
CNTSW 0
week
N/A N/A - - - - - - - - - - -
10
week
- - - - - - - - - - - - -
CNTLONG1 0
week
N/A N/A + + + + - - - + + + Yes (s)
10
week
+* + - - - - - - - - - - -
This table compiles and summarises data presented in Tables 2 and 3, and Figures 1, 2, 3 and 5. A cross indicates a statistically significant difference between
treatment and control (for fibre changes, 10 weeks compared with 0 weeks; for inflammatory responses, response to fibre sample compared with vehicle only). A
dash indicates no statistically significant difference.
(+ = statistically significant (p < 0.05); - = not statistically significant; (ns) = not significant; (s) = significant; N/A: not applicable)
* Note: The mass loss for CNTLONG1 10 weeks was just under statistical significance; however the mass losses at 3 weeks, 6 weeks and 24 weeks were significant,
and therefore representative statistical significance has been attributed to the 10 week sample here.
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macrophages as the inflammatory response is “walled
off” into the granuloma. The switching of inflammatory
action to the granulomas means that the leukocytes are
less easily lavaged, consistent with our observations for
LFC and LFA. In the presence of LFC, it is possible that
either the granulomas were slower to develop and did
not form within our time-frame, or that ongoing disso-
lution of the chrysotile fibres in the leukocytes made for
fewer granuloma. Indeed, there is evidence that the dis-
solution of chrysotile can be very rapid in vivo [27], and
so a very rapid in vivo dissolution of LFC here may have
elicited a transitory inflammatory response as the mag-
nesium from the chrysotile crystal lattice was released,
but no granuloma formed due to the absence of long
fibres. The observations for X607 are also interesting.
Although X607 showed mass loss and fibre shortening
and thinning, nevertheless long fibres with high aspect
ratios remained after in vitro incubation; but X607 eli-
cited only a minimal inflammatory response in mice
regardless of incubation time. This apparent non-con-
formity to the fibre pathogenicity paradigm could be
explained by a comparatively lower number of X607
fibres being injected into the mice, as the doses were
based on equal mass and the X607 fibres were the thick-
est and longest. Alternatively, glass inherently may be
less inflammogenic in biological systems compared to
other types of fibres [28-30], indicating that surface-
related properties (such as surface chemistry, surface
nanostructure, or curvature) may play a role in the bio-
logical response to fibres.
The length and aspect ratio of a fibre over the time of
its residence in the lungs will depend on its resistance
to degradation. Hence, knowledge of the durability of a
CNT sample, together with its ultimate shape, could
indicate its pathogenicity if it reaches the pleural cavity.
Three of the four types of CNTs investigated here were
durable in Gambles solution. These samples,
CNTTANG2, CNTSPIN and CNTSW, also revealed mini-
mal changes in morphology following the chemical
incubation. In an earlier study, the multi-walled sample,
CNTTANG2, which exists as tangled, long fibres, was
shown to be non-pathogenic when injected in the
abdominal cavities of mice [18]. While the difficulties of
working with the multi-walled CNTSPIN precluded in
vivo testing here, the single-walled CNTSW was injected
in the peritoneal cavity of mice and found to be non-
inflammatory, regardless of the incubation time. As the
mouse peritoneal cavity is responsive to long discrete
fibres, but not to compact particles or short fibres, these
results are consistent with the shapes of the aggregated
CNTs in each sample. Thus, although CNTTANG2 and
CNTSW were durable, the peritoneal cavity was not sen-
sitive to the shape of either [this work and [18]]. It
should be noted that the lack of an inflammatory
response in the abdominal peritoneal cavity from these
CNTSW does not necessarily imply they will be benign
in the lung (not investigated here) since the mesothe-
lium is only sensitive to long fibres. Other studies have
reported that intratracheal instillation, pharyngeal
aspiration, or inhalation of short SWCNTs induce
inflammatory and granuloma responses in the lungs of
mice [31-34].
The fourth type of CNT investigated here, CNTLONG1,
showed initial sensitivity to incubation in Gambles solu-
tion at least to 3 weeks (but possibly shorter as 3 weeks
was the first interrogation time), and thereafter the pro-
duct of the initial degradation appeared to be stable
with regards to mass. The profile of the time-dependent
dissolution of the CNTLONG1 sample is difficult to
explain. It is possible that the rapid loss of 30% mass
over the first three weeks of incubation could reflect the
loss of the small, curled-up CNTs that decorated the
longer fibres. However, inspection of electron micro-
scopy images of the CNTLONG1 after 0 weeks or 10
weeks incubation did not reveal any obvious difference
in the proportion of these decorating CNTs, suggesting
that this possibility, if it occurred, was unlikely to have
accounted for the total loss of mass observed. In addi-
tion, the percentage of very long fibres in this sample
progressively decreased from 0 to 3 to 10 weeks, while
the percentage of shorter fibres in the sample increased.
These changes in morphology were accompanied by a
mitigation of the strong inflammatory and fibrotic
response induced by fibres incubated for 0 weeks. The
inflammatory response from 0 weeks CNTLONG1 sam-
ples injected into the peritoneal cavities of mice is simi-
lar to that observed for LFA and 0 weeks LFC,
indicating that pristine CNTs, when present as discrete
long fibres, may show a pathogenicity equivalent to
some forms of long fibre asbestos when compared on a
mass basis, as has been observed previously [18]. How-
ever it should be noted that, because they are lighter, a
much-greater number of CNT fibres would be present
per unit weight compared with the heavier asbestos
fibres.
It could be argued that because we injected a pre-
sumed dose of 50 μg based on the assumption of zero
loss of mass, whereas the sample had actually shown a
30% loss of mass, the loss of pathogenicity observed
for CNTLONG1 10 weeks could be due to injecting
smaller actual doses. However, for a 30% loss of mass
we saw a substantial loss of toxicity in the CNTLONG1
10 weeks compared to 0 weeks samples. In contrast,
the LFA 10 weeks sample showed an apparent 25%
loss of mass, and was also injected as a presumed dose
of 50 μg, but no loss of toxicity was observed. TEM
data also indicate fibre shortening in the CNTLONG1
and LFC samples over time which was not observed
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for LFA; therefore we speculate that the observed loss
of toxicity with incubation in Gambles solution for
both CNTLONG1 and LFC can be attributed at least in
part to fibre shortening, consistent with a previous
study that pointed to a reduced inflammogenic poten-
tial of degraded SWCNTs [14].
Donaldson et al [35] have proposed that, similarly to
the fate of fibres reaching the parietal pleura, at the
peritoneal face of the diaphragm following intraperito-
neal injection, particles and short fibres may be cleared
through stomata whilst long fibres that cannot negotiate
the stomata are retained here, leading to inflammation
and fibrosis. Under this model, the inflammatory
response induced at 24 h by CNTLONG1 with 0 weeks
incubation in Gambles solution would indicate that the
long fibres of this sample are retained at the diaphrag-
matic stomata, and are still there at 7 d as evidenced by
the development of fibrotic plaques and the continued
inflammatory response. The much reduced inflamma-
tory responses at both 24 h and 7 d induced by the
CNTLONG1 sample incubated for 10 weeks in Gambles
solution is consistent with the shorter fibres in this sam-
ple being cleared, with fewer being retained at the dia-
phragmatic stomata.
A question remains over the kind of chemical reaction
that caused the loss of mass and fibre shortening in the
CNTLONG1 samples that was absent in the other CNT
samples. It has been suggested that synthesis defects
(such as point defects, or 5-membered or 7-membered
carbon rings in the sidewalls causing strain), and/or
removal of impurities during or after CNT synthesis
that can also introduce defects into the fibres, could act
as points of weakness for mechanical or chemical attack
and result in breakdown of CNTs [9]. Three recent stu-
dies investigating the biodegradation of short SWCNTs
when incubated in oxidizing environments [14-16] have
shown that the biodegradable SWCNTs carried surface
carboxylic acid groups. One of the studies showed that
only carboxylated SWCNTs were subject to biodegrada-
tion whereas pristine SWCNTs or those with other
kinds of surface functionalizations were not [15]. Ther-
mogravimetric analysis in another of these studies [16]
also showed a loss of mass in carboxylated SWCNTs
alongside biodegradation comparable to the loss of mass
we saw in our CNTLONG1 sample. These studies did not
address the biodegradation of MWCNTs. When we ana-
lysed our CNT samples by X-ray photoelectron spectro-
scopy (XPS), we found that the most oxygenated sample
was CNTSW, which had no mass loss. However, the dur-
able CNTTANG2 and the degradable CNTLONG1 had oxy-
gen levels similar to each other, but lower than observed
for CNTSW. We did not measure if the surfaces of our
samples were oxidized, but oxidative attack on
MWCNTs may result in successive layer removal
leading to thinner tubes [36], which we did not see.
Future studies are required to investigate the mechan-
ism(s) driving mass loss and fibre-shortening leading to
the reduced pathogenicity observed here for CNTLONG1,
and to determine if the mechanisms are applicable to
other MWCNTs.
Conclusions
In summary, we have found that three of the four types
of CNTs tested here showed close to 100% durability
after incubation for 24 weeks in a simulated biological
fluid, while a fourth lost mass, accompanied by a reduc-
tion in the proportion of long fibres in the sample. It is
important to note that three types of CNTs assessed
here were durable and therefore the fibre shortening
and loss of mass seen in the fourth sample (CNTLONG1)
cannot be generalised across all types of CNTs. Subse-
quent testing for inflammogenic potential using a fibre-
specific assay revealed that an adverse response in vivo
was dependent on both the durability and the presence
of discrete, long CNTs or fibre-shaped agglomerates of
CNTs in the sample: the durable but tightly agglomer-
ated bundles of short CNTSW elicited a minimal
response in mice, while the pristine, discrete, long, thin
fibres of CNTLONG1 induced an asbestos-like response,
which was mitigated after chemical incubation reduced
the proportion of fibres longer than 15 μm. These find-
ings add to growing evidence that biodurability and
pathogenicity are not consistent across all types of
CNTs. However, given the substantial response induced
in mice by the pristine fibres of CNTLONG1, and the fact
that the other three types of CNTs tested here were
durable, we would suggest that CNTs that are poten-
tially of pathogenic fibre dimensions should be treated
with a very high level of caution in the workplace to
avoid inhalation, as it is expected that the majority of
CNTs may be biopersistent. Clearly, though, if a CNT
can be designed and manufactured with safety in mind
without compromising its intended application, for
example with some kind of surface defect that makes it
vulnerable to chemical attack and degradation in biolo-
gical systems, or with a propensity to form clump-like
agglomerates that can be cleared, then there is the
potential for biological hazards to be minimised.
Methods
Characterisation of test samples
Seven fibrous samples were tested for their durability in
Gambles solution: four types of CNTs and three control
fibres. Two of the MWCNTs (CNTLONG1 and
CNTTANG2) and the SWCNT (CNTSW) were commer-
cial samples obtained from Mitsui & Co., NanoLab and
Sigma-Aldrich, respectively. The third type of MWCNT
tested (CNTSPIN) was prepared using a proprietary
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method and supplied by the CSIRO (Australia). For con-
trols, we assessed two types of asbestos fibres [amosite
(LFA) and chrysotile (LFC)] and one type of glass wool
fibre (X607). Two of the CNT samples used in this
study (CNTLONG1 and CNTTANG2) have been described
elsewhere [18]. However, these samples were charac-
terised again in this study to maintain consistency across
samples.
For quantification of contaminating metals, approxi-
mately 0.2-2.7 mg/ml of each sample was weighed into
an acid-cleaned digestion tube containing 0.2% (v/v)
HNO3. The samples were mixed and digested at room
temperature for 15 min after which the 0.2% HNO3
leach solution was filtered through acid-cleaned 0.45 μm
filter cartridges and analysed by matrix-matched stan-
dards using the techniques of inductively-coupled
plasma mass spectrometry (ICP-MS, Agilent 7500 CE)
or inductively-coupled plasma atomic emission spectro-
scopy (ICP-AES, Varian 730-ES).
For measurement of endotoxin levels, 1 mg/ml each
sample was vortexed for 1 min in limulus amebocyte
lysate (LAL) endotoxin-free water and incubated for 1 h
at 37°C. Samples were then centrifuged and endotoxin
levels in the supernatant were determined in triplicate
using the QLC-1000 Chromogenic LAL kit (Lonza, Aus-
tralia) following manufacturer’s instructions. A previous
trial had shown that centrifugation did not artificially
lower endotoxin levels in the supernatant. An aliquot of
each supernatant was also spiked with a known amount
of endotoxin and measured alongside unspiked samples
to confirm the absence of assay inhibition.
Samples were assessed for their potential to generate
free radicals by electron paramagnetic resonance (EPR).
TEMPONE-H (Enzo Life Sciences) was used as a spin
trap to quantify peroxynitrite and superoxide radical for-
mation. Samples were prepared by diluting the filtered
test samples that had been resuspended for injection to
0.01 mg/ml in saline. TEMPONE-H (1 μl of 100 mM
stock solution) was added to 99 μl of the diluted test
sample to obtain a final concentration of 1 mM TEM-
PONE-H. The samples were incubated at 37°C for 60
min after which the levels of oxidised TEMPONE-H
were quantified by EPR. Undiluted test samples at a pre-
sumed mass of 0.5 mg/ml were also assessed. Pyrogallal
in Hanks Buffered Solution was a positive control for
the TEMPONE-H reaction. A negative control for the
0.01 mg/ml samples was prepared by adding 2 μl 0.05%
BSA:saline to 97 μl saline. A negative control for the
undiluted test samples was prepared by using 99 μl
0.05% BSA:saline.
XPS analysis was performed using an AXIS Ultra DLD
spectrometer (Kratos Analytical Inc., Manchester, UK)
with a monochromated Al Ka source at a power of 150
W, a hemispherical analyser operating in the fixed
analyser transmission mode and the standard aperture
(0.3 mm × 0.7 mm slot). The total pressure in the main
vacuum chamber during analysis was typically less than
5 × 10-8 mbar.
Each specimen was analysed at an emission angle of 0°
as measured from the surface normal. Since the actual
emission angle is ill-defined in the case of particles (ran-
ging from 0° to 90° with respect to the surface normal)
the sampling depth may range from 0 nm to approxi-
mately 10 nm. All elements present were identified from
survey spectra (acquired at a pass energy of 160 eV).
The atomic concentrations of the detected elements
were calculated using integral peak intensities and the
sensitivity factors supplied by the manufacturer. The
accuracy associated with quantitative XPS is ca. 10% -
15%. Precision (i.e. reproducibility) depends on the sig-
nal/noise ratio but is usually much better than 5%. The
latter is relevant when comparing similar samples.
Full characteristics of the test samples are given in
Table 5.
In vitro assessment of biodurability
Gambles solution was prepared the day before addition
to the samples (per litre: 7.12 g NaCl; 1.95 g NaHCO3;
0.029 g CaCl2.2H2O; 0.148 g Na2HPO4; 0.079 g Na2SO4;
0.212 g MgCl2.6H2O; 0.118 g Glycine; 0.152 g Triso-
dium citrate.2H2O; 0.18 g Disodium tartrate.2H2O;
0.172 g Sodium pyruvate; 167 μl lactic acid). Formalde-
hyde (2 ml/L; 37% in formalin) was added to prevent
microbial growth. The pH was adjusted by HCl to 4.5
and then readjusted the next day prior to addition to
the samples.
For each time-point of interest, four replicates of each
test sample (each weighing 1.00-3.00 mg) were weighed
(Ohaus AP2500) into 7 ml plastic flat-bottomed Bijou
tubes. An appropriate amount of Gambles solution was
added to each sample to give a final concentration of
0.5 mg sample/ml. Samples were sonicated (Fisherbrand
ultrasonicating water bath, ultrasonic frequency: 40
kHz) until the CNTs or fibres were visually judged to
have dispersed as well as possible. Consequently, the
X607, LFA and LFC samples were sonicated for 20 min
and the CNT samples were sonicated for 1 h. All sam-
ples were then incubated with shaking for up to 24
weeks at 37°C with the Gambles solution refreshed
every 3 weeks. 0 weeks samples were treated identically
to incubated samples with the exception that after mix-
ing with Gambles solution they were immediately fil-
tered and dried, without sonication.
The four replicates of each sample were removed from
incubation at 0 weeks, 3 weeks, 6 weeks, 10 weeks and
24 weeks and filtered and washed with double-distilled
water (ddH2O) onto pre-weighed PVC filter papers (5.0
μm pore size, 25 mm diameter, SKC Inc). Blank
Osmond-McLeod et al. Particle and Fibre Toxicology 2011, 8:15
http://www.particleandfibretoxicology.com/content/8/1/15
Page 13 of 18
Table 5 Physicochemical properties of control fibres and CNT samples
Sample
Name
Description Diameter as
supplied by
manufacturer
(nm,
mean(SE)
Length as
supplied by
manufacturer
μ(m)
Endotoxin1
(pg ml-1)
Surface
groups
(atomic
ratio (X/C))
Soluble metals (μg g-1) Free
radical
generation
Morphology (SEM,
TEM, Light
Microscopy)
X607 Glass fibres NA NA ND N/A Li-0.41; Be-0.02; Al-3502;
V-1.07; Cr-4.05; Mn-29.6;
Fe-3142; Co-0.08; Ni-
2.62; Cu-0.72; Zn-7.09;
As-0.12; Sr-48.4; Mo-0.25;
Ag- < 0.01; Cd-0.02; Sb-
0.01; Pb-0.43; U-0.03
None Dispersed rod-like
glass fibres.
LFA Amosite
asbestos
NA NA ND N/A Li-0.15; Be-0.15; Al-463;
V-1.62; Cr-4.45; Mn-622;
Fe-~32003; Co-0.45; Ni-
2.67; Cu-2.96; Zn-2.9; As-
0.07; Sr-29.2; Mo-0.45;
Ag- < 0.03; Cd-0.02; Sb-
< 0.04; Pb-0.79; U-0.04
None Dispersed rod-like
amphibole asbestos.
LFC Chrysotile
asbestos
NA NA ND N/A Li- < 0.14; Be-0.01; Al-
137; V-1.29; Cr-32.3;
Mn-83.1; Fe-1220; Co-
5.54; Ni-140; Cu-0.77;
Zn-10.9; As- < 0.11; Sr-
2.26; Mo-0.08; Ag- <
0.08; Cd-0.04; Sb- <
0.09; Pb-0.46; U-0.02
None Dispersed fibrous-
looking chrysotile
asbestos.
CNTSW Single-
walled
1-2 0.5-2 ND C-1.0000; O-
0.0105; Si-
0.0004; Fe-
ND; Cl-
0.0005; S-
0.0002; Co-
0.0007; Ni-
0.0004
Li- < 0.04; Be- < 0.003;
Al-6.2; V-0.34; Cr-2.01;
Mn-15.7; Fe-185; Co-
442; Ni-47.4; Cu-1.13;
Zn-2.9; As-0.23; Sr-2.72;
Mo-144; Ag-0.03; Cd-
0.1; Sb- < 0.03; Pb-0.98;
U-0.04
None Bundles of tightly
agglomerated SWNTs
in which individual
NTs cannot be seen
CNTSPIN Multi-walled 8-10 200-300 ND C-1.0000; O-
0.0013; Si-
0.0007; Fe-
0.007; Cl-
ND; S-ND;
Co-0.0002;
Ni-0.0002
Li- < 0.02; Be- < 0.001;
Al-0.3; V-0.01; Cr-0.07;
Mn-0.02; Fe-50.1; Co- <
0.003; Ni-0.46; Cu-0.16;
Zn-0.95; As-0.12; Sr-
48.4; Mo-0.25; Ag- <
0.01; Cd-0.02; Sb-0.01;
Pb-0.43; U-0.001
None Agglomerated sheets
of very long fibres
with a hair-like
appearance.
CNTLONG1 Multi-walled 40-50 Mean 13 ND C-1.0000; O-
0.0046; Si-
0.0012; Fe-
ND; Cl-
0.0001; S-
0.0002; Co-
0.0001; Ni-
0.0002
Li- < 0.09; Be- < 0.007;
Al-0.9; V-0.01; Cr-0.15;
Mn-0.09; Fe-15.6; Co- <
0.01; Ni-0.2; Cu-0.06;
Zn-2.5; As- < 0.07; Sr-
0.84; Mo-0.01; Ag- <
0.05; Cd- < 0.02; Sb- <
0.06; Pb-0.03; U-0.01
None Bundled or individual
MWNTs of variable
length, many in the 10
20(m range or longer.
Many very short fibres
often decorate the
longer fibres.
CNTTANG2 Multi-walled 15 ± 5 5-20 ND C-1.0000; O-
0.0038; Si-
0.0009; Fe-
ND; Cl-ND;
S-0.0005;
Co-0.0007;
Ni-0.0003
Li- < 0.08; Be- < 0.006;
Al-41.6; V- < 0.01; Cr-
0.03; Mn-0.05; Fe-606;
Co-0.04; Ni-0.44; Cu-
1.07; Zn-9.5; As- < 0.07;
Sr-0.3; Mo-655; Ag- <
0.05; Cd-0.04; Sb- <
0.06; Pb-0.26; U- <
0.006
None Bundles of intermediate-
length MWNTs. Often
stellate in form with
longer fibres protruding
from the central tangled
agglomerate, a large
proportion of which are
in respirable size range
< 5 (m.
Note: Lengths and widths as determined by authors can be found in Table 3
NA: Not available
ND: Not detected
N/A: Not applicable
1Endotoxin detection limit < 10 pg ml-1
2Analysed by ICP-AES
3Value over range, and is an estimate only
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Gambles solution was also washed through five filter
papers to control for mass not attributable to the recov-
ered CNTs or fibres. The filtered samples were left to
dry protected from dust at room temperature for five
days, and then weighed to 0.001 mg (Sartorius MC5-
OCE), and percent recoveries relative to recovery at 0
weeks were calculated.
Statistical significance of loss of mass across the time
points for each sample type was assessed by one-way
analysis of variance (ANOVA) with Tukey’s Multiple
Comparison post test.
For morphological assessment by SEM, samples of
each CNT or fibre that had been incubated in Gambles
solution for 0 weeks or 10 weeks were filtered on What-
man PC filter membranes (0.2 μm pore size, 25 mm dia-
meter) and viewed by SEM (Hitachi S-2600N). EDX
(Inca System, Oxford Instruments) linked to the SEM
was used to confirm that the major elements present in
the samples being viewed were consistent with what was
expected.
For measurement by TEM, samples of each CNT or
fibre that had been incubated in Gambles solution for 0
weeks or 10 weeks were filtered on PVC filter papers
(5.0 μm pore size, 25 mm diameter, SKC Inc.). To pre-
pare the samples for TEM, small fragments of filtered
material were removed from filter paper with forceps
and suspended in 50-100 μl ethanol by gentle sonication
in a water bath for up to 3 h, with samples of the same
type always sonicated for equivalent periods of time.
Addition of 1% triton or sonication for longer times did
not improve the degree of dispersion. Aliquots of each
dispersion (5 μl) containing small fragments of material
(visible to the naked eye) were pipetted onto carbon-
coated 100 mesh copper grids. Grids were examined in
a Tecnai 12 TEM (FEI, Eindhoven, Netherlands) operat-
ing at 120 kV at a variety of different magnifications.
Images were recorded using a MegaView III CCD cam-
era (Olympus) and AnalySiS software. Measurements
were made using Image J (NIH) calibrated via the
embedded scale bar.
The technical difficulties in measuring the lengths and
diameters of CNTs within bundles should be noted
here, and therefore the measurements included in Table
3 should be regarded only as trends rather than absolute
values. For the measurements reported here, a number
of images for each sample were examined and all fibres
in a given image that had a discernible length or width
were measured for that aspect. When a straight fibre
passed over a grid line and did not emerge from the
other side, the mid-point of that grid line was measured
as the end of that fibre. If two or more CNTs over-
lapped with one another such that the lengths and/or
diameters of individual fibres could not be determined,
those CNTs were excluded from measurement. As we
were interested in time-dependent alterations in the
proportions of long to short fibres, we included fibres
with lengths > 5 μm for representative purposes,
although these measurement rules depart from the
World Health Organisation’s guidelines.
To increase confidence in our measurements, two sets
of measurements were performed by two individual
operators and an average of 100 measurements was
made per sample, although the number of measure-
ments for samples in which individual fibres were diffi-
cult to identify were considerably lower (e.g. only 23
measurements were possible for determining the lengths
of CNTSW).
In vitro determination of the impact of sonication on
CNTLONG1 mass loss and fibre changes
Quadruplicate CNTLONG1 samples were weighed as
described, then either sonicated in Gambles solution for
1 h under conditions identical to the main experiment
and filtered, dried and weighed, or washed in Gambles
solution and immediately filtered, dried and weighed,
replicating the conditions by which we produced our
original 0 weeks samples. Sample recoveries and fibre
lengths were measured as described above.
In vivo assessment of inflammogenic potential
Samples of X607, LFA, LFC, CNTSW and CNTLONG1
that had been filtered after 0 weeks or 10 weeks incuba-
tion were used to investigate the impact of incubation
in Gambles solution on inflammogenic potential in vivo
in mice. CNTTANG2 was not assessed as it had pre-
viously been shown not to elicit an inflammatory
response in mice [18]. CNTSPIN was not assessed due to
sample characteristics that made it impossible to obtain
a good dispersion in 0.5% BSA:saline, and therefore we
could not be confident of injecting a known mass for in
vivo evaluation.
Four female C57Bl/6 mice aged 8 weeks were used for
each sample type at each selected time-point, plus three
control mice that were injected with vehicle only. Mice
were housed at the University of Edinburgh Biological
Research Facility under standard housing conditions of
12 h light/dark cycles, and food and water was available
ad libitum. All procedures were conducted in accor-
dance with Edinburgh University guidelines.
The samples (residues after filtering, washing and dry-
ing) were resuspended with sonication in 0.5% BSA (1 h
bath sonication (Fisherbrand ultrasonicating water bath)
ultrasonic frequency: 40 kHz) followed by 10 sec probe
sonication (Bandelin Electronics Status US 70, Berlin,
Germany: 60% power using pulsing) in sterile saline at
their presumed original mass of 0.5 mg/ml. Based on
this presumed 100% recovery of original mass, 50 μg
each sample, or vehicle only, was injected into the
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mouse peritoneal cavity. After 24 h or 7 d the mice were
sacrificed by asphyxiation in 100% CO2 and the perito-
neal cavity of each mouse was washed (lavaged) three
times with 2 ml sterile saline using a 21 gauge needle.
The first wash was stored in a chilled 1.5 ml Eppendorf
tube, and the second and third washes were combined
in a conical 15 ml falcon tube, both on ice.
Following sacrifice and lavage at the 7 d time-point
only, the peritoneal cavity was exposed via lateral inci-
sions in the abdominal wall extending to the vertebral
column, which was severed below the diaphragm. The
ribcage around the diaphragm was then cut from each
mouse, taking care not to tear the diaphragm, rinsed by
gentle immersion in ice-cold sterile saline and stored in
‘methacarn’ fixative (60% methanol, 30% chloroform,
10% acetic acid) at room temperature for approximately
five days. The diaphragm was then carefully excised
from the surrounding ribcage and stored in 70% ethanol
until processed for histology.
To pellet cells obtained by lavage, samples in the 1.5
ml tubes were centrifuged at 2000 rpm for 5 min at
room temperature and the combined washes in the 15
ml tubes were centrifuged at 123 g for 5 min at room
temperature. From the first wash a 1 ml aliquot of
supernatant was transferred to a fresh 1.5 ml Eppendorf
tube and stored at -20°C for quantification of Interleu-
kin-6 (IL-6). A further 200 μl from the first wash was
combined in a fresh 1.5 ml Eppendorf tube with 400 μμl
supernatant from the second and third washes and
stored at 4°C for quantification of lactate dehydrogenase
(LDH) and total protein levels.
To prepare slides for total and differential cells counts,
the remaining supernatants were discarded and the cell
pellets from each of the second and third washes were
resuspended in 500 μl 0.01% BSA:saline, and then com-
bined with the pellet from the first wash, which was
completely resuspended by gentle pipetting. An aliquot
(10 μl) was diluted 1:10 in sterile saline and total cell
numbers were counted using a NucleoCounter (Chemo-
Metec, A/S, Allerød, Denmark) following standard pro-
tocol. Briefly, to the 100 μl containing 10-fold diluted
samples was added 100 μl lysis buffer (ChemoMetic
Reagent A) followed by 100 μl stabilisation buffer (Che-
moMetic Reagent B). The lysed solution was drawn up
into a NucleoCounter and the diluted cell count
obtained.
After total numbers for each sample had been calcu-
lated (diluted cell count X10), samples were prepared
for differential cell counting. Glass slides (Thermoscien-
tific) were labelled and then placed in a cytospin slide
cassette with filter cards (ThermoShandon) and placed
in a cytospin centrifuge (Cytospin 4, ThermoShandon).
BSA (300 μl 0.01% in saline) was added to the cassette
and the cell suspension was added at an appropriate
volume to obtain ~40,000 cells/slide. The cassettes were
centrifuged at 300 rpm for 3 min at room temperature
after which the slides were removed and allowed to dry
at room temperature. Once dried, the slides were fixed
in 100% methanol, and then stained with eosin (Diff-
QuickI, Dade Behring) followed by hematoxylin (Quick-
Diff Blue, Reastain). Differential cell counting was per-
formed using light microscopy.
The bicinchinonic acid (BCA) protein assay (Sigma
Aldrich) was used to measure total protein concentration
of the peritoneal lavage fluid. The test reagent (1 part
copper (II) sulphate solution (4% w/v) to 50 parts BCA)
was added to the standards and lavage samples, which
were then incubated at 37°C for 30 min. The absorbance
of solutions in plates was read at 570 nm using a Synergy
HT microplate reader (BioTek Instruments). The protein
concentration of each sample was established by interpo-
lation from a BSA standard curve (0-1000 μg/ml).
Concentrations of IL-6 in the peritoneal lavage sam-
ples were determined by ELISA (IL-6 Duoset, R&D Sys-
tems). The samples and standards were added to 96-
well plates pre-coated with IL-6 capture antibody and
incubated at room temperature for 2 h. Each well was
thoroughly washed with 0.05% Tween 20/PBS before
incubation with IL-6 detection antibody at room tem-
perature for 2 h. Wells were washed again followed by
20 min incubation with Streptavidin-HRP conjugate.
The wash step was repeated before the addition of sub-
strate solution (3,3’,5,5’-tetramethylbenzidine, Sigma) to
each well. Plates were incubated in the dark at room
temperature until the colour had developed sufficiently,
after which the reaction was stopped by the addition of
50 μl 2 N H2SO4 per well. Absorbance at 450 nm was
read. The IL-6 concentration in each sample was estab-
lished by comparison with an IL-6 standard curve (0-
100 pg/ml).
Levels of LDH in the peritoneal lavage fluid were
assessed using the LDH detection kit (Roche Applied
Science). Following addition of the test reagent (diaphor-
ase/NAD+ catalyst mixture diluted in iodotetrazolium
chloride (INT) and sodium lactate dye solution), samples
were incubated in darkness at room temperature for 30
min after which absorbance was read at 490 nm.
To detect the presence of fibrotic plaques in the
excised diaphrams, and measure their sizes, 4 μm-thick
diaphragm sections were stained with hematoxylin and
eosin, and serial images were taken using QCapture Pro
software (Media Cybernetics Inc., MD, USA). The
images were realigned using Photoshop Elements 4CS3
(Adobe Systems Inc.) and the total length of each dia-
phragm along the basement membrane was measured
using calibrated Image-Pro Plus software (Media Cyber-
netics Inc., MD, USA). The area of each detected fibro-
tic plaque was measured, excluding areas of adherent
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tissue such as liver, connective tissue or lymphatic tis-
sue. The area of fibrotic plaque on each diaphragm (in
mm2) was expressed per unit length of diaphragm (in
mm) to give fibrotic plaque area per unit diaphragm
length (mm2/mm). Average results were calculated from
four separate animals for each treatment and statistical
significance was assessed by one-way ANOVA with
Tukey’s Multiple Comparison post test.
Statistics
All data are expressed as the mean ± the standard error
of the mean (SE). Statistical tests were performed using
GraphPad Prism 5.01 (GraphPad Software, San Diego,
USA). Comparisons between two groups were analysed
using unpaired t-tests, and multiple comparisons were
analysed using one-way ANOVA with Tukey’s Multiple
Comparison post test. For all tests, values of p < 0.05
were considered statistically significant.
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